Efficacy of folic acid therapy for prevention of in-stent restenosis: A randomized clinical trial

Archives of Iranian Medicine

Volumn 9, Issue 2, 2006, Pages 108-110

  Namazi, Mohammad Hassan ^a   Motamedi, Mohammad Reza ^a   Safi, Morteza ^a   Vakili, Hossein ^a   Saadat, Habibollah ^a   Nazari, Neshat ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Folic acid; Hemocysteinemia; In stent restenosis; Percutaneous coronary angioplasty (PTCA); Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FOLIC ACID; HEPARIN; HOMOCYSTEINE; PLACEBO; TICLOPIDINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; EXERCISE TOLERANCE; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; STENTS;

EID: 33645762348     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Braunwald E, Zipes DP, Libby P. Heart Disease: a Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: Saunders; 2001: 1025-1027.
2. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA. 1995; 274: 1049-1057.
3. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997; 95: 1119-1121.
4. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001; 345: 1593-1600.
5. Seshadri N, Robinson K. Homocysteine, B vitamins, and coronary artery disease. Med Clin North Am. 2000; 84: 215-237.
6. Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentration: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998; 97: 437-443.
7. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976; 57: 1079-1082.
8. No authors listed. Lowering blood homocysteine with folic acid-based supplements: metaanalysis of randomized trials. Homocysteine Lowering Trialists' Collaboration. BMJ. 1998; 316: 894-898.
9. Genser D, Prachar H, Hauer R, Halbmayer WM, Mlczoch J, Elmadfa I. Relation of homocysteine, vitamin B12, and folate to coronary in-stent restenosis. Am J Cardiol. 2002; 89: 495-499.